Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Immune profile of an atypical EAE model in marmoset monkeys immunized with recombinant human myelin oligodendrocyte glycoprotein in incomplete Freund's adjuvant.
LOTUS, a possible endogenous inhibitor of axonal degeneration, as a new biomarker for multiple sclerosis.
Tyrosine Kinase Inhibitor as a new Therapy for Ischemic Stroke and other Neurologic Diseases: is there any Hope for a Better Outcome?
The Emerging Roles of Gamma-Delta T Cells in Tissue Inflammation in Experimental Autoimmune Encephalomyelitis.
The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence.
Vitamin D-related gene expression profiles in immune cells of patients with relapsing remitting multiple sclerosis.
VZV encephalitis that developed in an immunized patient during fingolimod therapy.
Pregnancy Data in a Turkish Multiple Sclerosis Population.
Diagnostic work-up and therapeutic options in management of pediatric status epilepticus.
Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis.
Researchers Expand Focus on Progressive Forms Of Multiple Sclerosis: Efforts to Pinpoint the Beginning of Disease May Yield Clues to Treatment.
[Animal models for multiple sclerosis].
Cognitive dysfunction in multiple sclerosis: Usually forgotten in the clinical assessment of MS patients.
A pilot study to improve adherence among MS patients who discontinue treatment against medical advice.
Natalizumab treatment in multiple sclerosis: the experience from two Brazilian MS centers.
No evidence for a role of Ile587Val polymorphism of EIF2B5 gene in multiple sclerosis in Kashmir Valley of India.
Risk factors of early onset of MS in women in reproductive age period: survival analysis approach.
[Argyrophil fibrils in the foci of multiple sclerosis; tissue in the central nervous parenchyma].
Decoding diffusivity in multiple sclerosis: analysis of optic radiation lesional and non-lesional white matter.
Alemtuzumab for the treatment of multiple sclerosis.
Need for differentiation of real and clinical important change in research on responsiveness of walking outcome measures in multiple sclerosis.
Is it correct for a woman with multiple sclerosis to forgo medication because she may become pregnant?
[Animal models of Charcot-Marie-Tooth disease and their relevance for understanding the disease in humans.]
New insights in the pathophysiology and treatment of multiple sclerosis spasticity and related symptoms. Foreword.
Relapsing Remitting Multiple Sclerosis in an Iranian Patient with Neurofibromatosis Type I.

Pages